J. Benjamin Guise

Researcher

University of Arkansas for Medical Sciences

faculty

7 h-index 14 pubs 200 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

J. Benjamin Guise's research program focuses on the pharmacological treatment of substance use disorders and related behavioral health interventions. His recent publications investigate the efficacy of gabapentin, particularly in conjunction with buprenorphine-assisted tapers and transition to injectable naltrexone for opioid use disorder. He has also examined the impact of fentanyl on treatment outcomes within outpatient buprenorphine tapers when gabapentin is used as an adjunct therapy. Further studies explore the effects of gabapentin and d-cycloserine, alone and in combination with naloxone, on methadone-maintained individuals within controlled behavioral discrimination procedures.

Guise's work involves collaborations with researchers at the University of Arkansas for Medical Sciences, including Michael Mancino and Alison Oliveto, with whom he has co-authored multiple publications. His scholarship metrics include an h-index of 7, with a total of 14 publications and 200 citations.

Metrics

  • h-index: 7
  • Publications: 14
  • Citations: 200

Selected Publications

  • Randomized, placebo-controlled trial of gabapentin during outpatient buprenorphine-assisted taper and transition to injectable naltrexone (2025) DOI
  • Gabapentin and D-cycloserine alone and in combination with naloxone in methadone-maintained humans responding under a naloxone novel-response discrimination procedure (2025) DOI
  • THE IMPACT OF FENTANYL ON TREATMENT OUTCOMES DURING AN OUTPATIENT BUPRENORPHINE TAPER WITH ADJUNCT GABAPENTIN (2024) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics